Leukodystrophy Research and Clinical Trials

As part of a leading research hospital, we have access to resources that many other hospitals don’t. This includes the latest clinical trials and cutting-edge treatments. Our team is always working to improve our understanding of leukodystrophies and find better ways to help children with these conditions.

The director of the Leukodystrophy Clinic, Keith Van Haren, MD, is also the director of the Van Haren Lab, which is at the forefront of leukodystrophy research and care.

At the Leukodystrophy Clinic, we’re committed to providing your child and family with the most effective and compassionate care available. 

For questions about our clinical trials, please contact Sweta Patnaik at sweta@stanford.edu.